167 related articles for article (PubMed ID: 30419774)
21. Frequency and factors associated with use of videolaryngostroboscopy in voice disorder assessment.
Cohen SM; Thomas S; Roy N; Kim J; Courey M
Laryngoscope; 2014 Sep; 124(9):2118-24. PubMed ID: 24659429
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
23. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
24. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
[TBL] [Abstract][Full Text] [Related]
25. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
[TBL] [Abstract][Full Text] [Related]
26. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
[TBL] [Abstract][Full Text] [Related]
27. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
[TBL] [Abstract][Full Text] [Related]
28. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
30. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
[TBL] [Abstract][Full Text] [Related]
31. [Three cases of muscle tension dysphonia improved using proton pump inhibitors].
Mesuda Y; Oridate N; Nishizawa N; Mori M; Dohsaka Y; Furuta Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2007 May; 110(5):416-9. PubMed ID: 17564132
[TBL] [Abstract][Full Text] [Related]
32. Risk of acute kidney injury in patients with HIV receiving proton pump inhibitors.
Sutton SS; Magagnoli J; Cummings TH; Hardin JW
J Comp Eff Res; 2019 Jul; 8(10):781-790. PubMed ID: 31167563
[No Abstract] [Full Text] [Related]
33. Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia.
Hung TH; Tseng CW; Tsai CC; Lee HF
PLoS One; 2019; 14(4):e0216041. PubMed ID: 31022265
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy and the risk for community-acquired pneumonia.
Gau JT; Acharya U; Khan S; Heh V; Mody L; Kao TC
BMC Geriatr; 2010 Jul; 10():45. PubMed ID: 20604960
[TBL] [Abstract][Full Text] [Related]
35. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
36. Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database.
Conrady CD; Pradeep T; Yu Y; Johnson MW; VanderBeek BL
Ophthalmol Retina; 2023 Mar; 7(3):261-265. PubMed ID: 36058521
[TBL] [Abstract][Full Text] [Related]
37. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
38. Community-acquired pneumonia in older veterans: does the pneumonia prognosis index help?
Mody L; Sun R; Bradley S
J Am Geriatr Soc; 2002 Mar; 50(3):434-8. PubMed ID: 11943037
[TBL] [Abstract][Full Text] [Related]
39. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
40. Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.
Yadlapati R; Pandolfino JE; Lidder AK; Shabeeb N; Jaiyeola DM; Adkins C; Agrawal N; Cooper A; Price CP; Ciolino JD; Gawron AJ; Smith SS; Bove M; Tan BK
Am J Gastroenterol; 2016 Nov; 111(11):1517-1524. PubMed ID: 27091320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
